About Cohera

Management Team

Patrick Daly

Patrick Daly

President & CEO

Mr. Daly has more than 25 years of experience in the medical device industry and has held leadership positions in sales, marketing, international marketing and positions of increasing responsibility throughout various Johnson & Johnson companies including Ethicon Endo-Surgery, Ethicon Products, J&J Medical Australia/New Zealand, and J&J Medical Asia Pacific.  Mr. Daly started Cohera Medical, Inc® in January 2006 and led successful funding rounds of over $125M in capital from private investors and private equity to facilitate Cohera Medical’s two lead products; TissuGlu® Surgical Adhesive and Sylys® Surgical Sealant through the FDA approval process for medical devices and commercialization in the U.S and EU.  Cohera has over 70 patents issued and pending, and Mr. Daly holds a patent for the surgical sealant technology.  Prior to starting Cohera Medical and his work at Johnson & Johnson, Mr. Daly spent over four years on active duty in the U.S. Army as a field artillery officer.  He is a graduate of the U.S. Military Academy at West Point where he received a Bachelor of Science Foreign Area Studies (Latin America). He played varsity lacrosse during his four years at West Point and was an All-American.  Mr. Daly currently represents the medical device industry by serving on the board of directors for AdvaMed (Advanced Medical Technology Association) as well as chairman of the Accel Board for smaller companies with revenue less than $100M.  His not for profit board membership includes The Johnny Mac Soldiers Fund (JMSF), (www.johnnymac.org) a 501(c)(3) non-profit committed to helping veterans and their families through education.

Dottie Clower

Dottie Clower, Ph.D.

Chief Scientific Officer

Dr. Clower was instrumental in the early formation of Cohera dating back to 2003 and led the development of Cohera from its ideation to its successful seed financing. She currently leads Cohera’s product development program, and her team successfully brought the company’s lead product TissuGlu® from laboratory prototype through FDA approval as a Class III PMA medical device. Prior to joining Cohera, she specialized in commercializing early-stage technologies through her leadership position in the University of Pittsburgh’s Office of Enterprise Development. Dr. Clower is a neuroscientist and chemist with over twenty years of research experience in both industrial and academic environments. Her work has been published in Nature, Journal of Neuroscience, Journal of Neurophysiology, Cerebral Cortex and Plastic and Reconstructive Surgery. She also brings experience from Baxter Healthcare where she worked on the development of pre-mixed I.V. drug delivery systems within Baxter’s Pharmaceutical R&D Division. Dottie holds a B.A. in Chemistry from Northwestern University in Chicago and a Ph.D. in Neuroscience from Emory University in Atlanta. In 2012, she cofounded the Pittsburgh chapter of Women in Bio and served as Chapter Chair until 2014. She is also a member of the Women Presidents Organization (WPO).

Chad Coberly

Chad Coberly, J.D.

Chief Clinical & Legal Officer

Chad joined the Company in 2008.  He has more than 20 years of experience, primarily in the areas of medical device regulatory, clinical affairs, compliance, quality systems, intellectual property, business development, litigation, and general legal affairs. Prior to joining Cohera, he served as the VP of Legal and Regulatory Affairs for Zassi Medical Evolutions, where he lead the regulatory and legal aspects of the Worldwide commercialization and later the successful divestiture of a gastrointestinal catheter line. He brings intellectual property experience from the law firm of Howard and Howard, and experience from the Surgical Group of the Stryker Corporation where he held regulatory and legal related positions. Chad holds a J.D. from Michigan State University and a bachelor’s degree in biomedical engineering from Tulane University. He also has conducted M.B.A. studies at Boston University. He is admitted to practice before the U.S. Patent and Trademark Office and is a member of the Michigan Bar.

Mart Pearson

Mart Pearson

Vice President, Europe

Mart Pearson has more than 26 years of experience in international sales and marketing of medical devices, working primarily on the introduction of innovative, first-to-market technologies in surgery (surgical oncology, minimally invasive surgery, endoscopy, orthopedics, spine surgery, general surgery) and infection prevention.. He has been responsible for definition of strategies, identification of initial target markets, creation and management of teams and organizations, management of Key Opinion Leader and Clinical Evidence development as well as all aspects of the supporting logistics and infrastructure required for early stage medical device sales, both direct and through distributor organizations. During his tenure as Vice President, International, at Salient Surgical Technologies Inc. (now a part of Medtronic’s Advanced Energy ) he led the introduction of the company’s saline-enhanced radiofrequency product platform to the European markets starting in 2001 and was responsible for all markets outside of the U.S. from 2005 through 2008. Prior to that, he was responsible for opening one of the first international subsidiaries of STERIS Corporation, where, with direct sales, customer service, clinical education and technical support teams he successfully established the SYSTEM 1 low temperature liquid sterilization system as market leader in Italy. Mr. Pearson received his BA from Pomona College, where he majored in Philosophy while also pursuing languages (Russian, Swedish) and Economics. He continues to pursue his interests in new market development, entrepreneurial business, languages, food, wine, cross cultural communications and management. He is located in Northern Italy.

Stephanie Kladakis

Stephanie Kladakis, Ph.D.

Vice President of R&D

Dr. Kladakis has more than 14 years of experience in implantable medical device product development, primarily in the orthopedic, cardiovascular and general surgery areas.  She currently leads Cohera Medical’s Product Development efforts, and her team successfully brought the company’s second product, Sylys® Surgical Sealant, from laboratory prototype through human clinical trials. Prior to joining Cohera Medical, Dr. Kladakis was Program Manager for NMT Medical where she led a team to develop a bioabsorbable, transcatheter cardiovascular implant for structural heart repair.  Dr. Kladakis also developed biologic-based orthopedic implants while working at DePuy Biologics, a division of Johnson & Johnson.  Dr. Kladakis’s academic research experience focused on cardiovascular tissue engineering.  Dr. Kladakis is an inventor on 9 US patents and numerous pending applications. Dr. Kladakis holds a B.S. in Engineering Sciences from Harvard University in Cambridge and a Ph.D. in Mechanical Engineering from the Georgia Institute of Technology in Atlanta.